In this week's video, Dr. Brian Durie discusses the first monoclonal antibody approved for myeloma treatment - Darzalex (daratumumab). 

Bottom Line:

Darzalex is a useful drug that has some drawbacks in terms of testing.

Image of Dr. Brian G.M. DurieDr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.


Previous Post
ASH 2015: Autologous Transplantation for Multiple Myeloma in the Era of New Drugs
Next Post
#AskDrDurie: What should we know about the FDA approval of ixazomib (Ninlaro®)?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.